An Online Intervention Addressing Mental Health and Substance Use in University Students
An Integrated Online Intervention Addressing Mental Health and Substance Use in University Students: A Randomized Controlled Trial
1 other identifier
interventional
1,489
1 country
1
Brief Summary
The purpose of this study is to assess the effectiveness of mobile app containing a range of evidence based tools to improve the mental health and substance use outcomes of university students.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable anxiety
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 2, 2022
CompletedStudy Start
First participant enrolled
September 28, 2022
CompletedFirst Posted
Study publicly available on registry
November 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2023
CompletedSeptember 18, 2023
September 1, 2023
10 months
September 2, 2022
September 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in General anxiety symptomology from Baseline to Follow-up at 30 days
Assessed by the General Anxiety Disorder 7-Item (GAD-7) scale. Changes in anxiety symptomology from baseline to follow-up at 30 days will be based on total scores on the GAD-7 in both the intervention and control groups. Total scores range from 0 to 21 with higher scores indicating a worse outcome (i.e, a greater frequency of anxiety symptoms).
The GAD-7 will be administered to both the intervention and control groups at baseline and 30 days.
Change in Depressive symptomology from Baseline to Follow-up at 30 days
Assessed by the Patient Health Questionnaire 9-item (PHQ-9) scale. Changes in depressive symptomology from baseline to follow-up at 30 days will be based on total scores on the PHQ-9 in both the intervention and control groups. Total scores range from 0 to 29 with higher scores indicating a worse outcome (i.e., a greater frequency of depression symptoms).
The PHQ-9 will be administered to both the intervention and control group at baseline and 30 days.
Change in Alcohol consumption risk from Baseline to Follow-up at 30 days
Assessed by the alcohol consumption questions of the Alcohol Use Disorders Identification Test, Adapted for Use in the United States (USAUDIT-C). Changes in alcohol consumption risk from baseline to follow-up at 30 days will be based on total scores on the USAUDIT-C in both the intervention and control groups. Total scores range from 0 to 18 with higher scores indicating a worse outcome (i.e., a higher level of risky drinking).
The USAUDIT-C will be administered to the intervention and control groups at baseline and 30 days.
Secondary Outcomes (10)
Frequency of cannabis consumption
Frequency of cannabis consumption will be assessed in the intervention and control groups at baseline and at 30 days.
Frequency of binge drinking
Frequency of binge drinking will be assessed in the intervention and control groups at baseline and at 30 days.
Frequency of alcohol use
Frequency of alcohol use will be assessed in the intervention and control groups at baseline and at 30 days.
Frequency of opioid use
Frequency of opioid use will be assessed in the intervention and control groups at baseline and at 30 days.
Frequency of non-medical stimulant use
Frequency of non-medical stimulant use will be assessed in the intervention and control groups at baseline and at 30 days.
- +5 more secondary outcomes
Study Arms (2)
Intervention arm
EXPERIMENTALParticipants randomized into the intervention arm will be given immediate access to a fully functional version of the Minder app that includes baseline, interim and follow-up surveys and access to all app components and e-coaching.
Control arm
NO INTERVENTIONParticipants randomized into the control arm will be given access to a restricted version of the app that only includes access to a generic study introduction video and baseline and follow up survey assessments delivered via the app.
Interventions
There are four main components of the Minder app: The Chatbot, Services, Community, and Peer Coaching components. The Services component asks participants to complete a series of questions on various mental health, substance use, and general life issues. It then recommends community and on-campus resources based on their current needs. The Community component of the app matches individuals with groups (e.g., student clubs) and events at the university or in the broader community that they may be interested in. The Chatbot component of the app contains pre-formatted conversational scripts that users engage with via a "chatbot" and videos designed to teach evidence-based skills (e.g., cognitive strategies to manage anxiety) that can be applied to everyday life. To support use of the app, all users in the intervention group will be offered access to trained peer coaches to help users navigate the different app components and provide non-clinical peer support.
Eligibility Criteria
You may qualify if:
- Must be currently enrolled at participating university
- Must be 17 years or older
- Must have access to and be able to use a smart phone with Wi-Fi and/or mobile data
- Must be English speaking
You may not qualify if:
- \) Any participants that self-identify as currently having a suicidal plan at the time of study enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of British Columbia
Vancouver, British Columbia, V6T 2A1, Canada
Related Publications (3)
Y Wang A, Vereschagin M, G Richardson C, J Munthali R, Xie H, L Hudec K, Mori T, Munro L, V Vigo D. Examining the effects of engagement with an app-based mental health intervention: a secondary analysis of a randomized control trial with treatment non-compliance. Int J Ment Health Syst. 2025 Oct 9;19(1):30. doi: 10.1186/s13033-025-00688-4.
PMID: 41068963DERIVEDVereschagin M, Wang AY, Richardson CG, Xie H, Munthali RJ, Hudec KL, Leung C, Wojcik KD, Munro L, Halli P, Kessler RC, Vigo DV. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial. J Med Internet Res. 2024 Mar 27;26:e54287. doi: 10.2196/54287.
PMID: 38536225DERIVEDWang AY, Vereschagin M, Richardson CG, Xie H, Hudec KL, Munthali RJ, Munro L, Leung C, Kessler RC, Vigo DV. Evaluating the Effectiveness of a Codeveloped e-Mental Health Intervention for University Students: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2023 Aug 30;12:e49364. doi: 10.2196/49364.
PMID: 37647105DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel V Vigo, MD, Lic. Psych, DrPH
University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Single blinded in that only the investigators (including the statistician) will be blinded to the treatment group assignment when examining the primary hypotheses.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 2, 2022
First Posted
November 4, 2022
Study Start
September 28, 2022
Primary Completion
July 21, 2023
Study Completion
July 21, 2023
Last Updated
September 18, 2023
Record last verified: 2023-09